Group One Trading, L.P. Intra Cellular Therapies, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 1,432 shares of ITCI stock, worth $182,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,432

Previous 6,641 78.44%

Holding current value

$182,164

Previous $454,000 77.09%

% of portfolio

0.0%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $354,159 - $421,095	-5,209 Reduced 78.44%	1,432 $104,000
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $62,428 - $76,965	-964 Reduced 12.68%	6,641 $454,000
Q1 2024 May 10, 2024	SELL	$64.37 - $75.65 $380,619 - $447,318	-5,913 Reduced 43.74%	7,605 $526,000
Q4 2023 Feb 14, 2024	BUY	$46.37 - $73.65 $626,829 - $995,600	13,518 New	13,518 $968,000
Q4 2022 Feb 09, 2023	BUY	$44.07 - $54.45 $243,883 - $301,326	5,534 Added 381.66%	6,984 $369,000
Q3 2022 Nov 09, 2022	BUY	$42.7 - $59.99 $61,915 - $86,985	1,450 New	1,450 $67,000
Q1 2022 May 12, 2022	SELL	$38.74 - $62.09 $369,618 - $592,400	-9,541 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$35.2 - $53.42 $636,662 - $966,207	-18,087 Reduced 65.47%	9,541 $499,000
Q3 2021 Nov 12, 2021	BUY	$28.72 - $42.49 $454,752 - $672,786	15,834 Added 134.25%	27,628 $1.03 Million
Q2 2021 Aug 10, 2021	SELL	$29.3 - $44.5 $64,167 - $97,455	-2,190 Reduced 15.66%	11,794 $481,000
Q1 2021 May 12, 2021	BUY	$30.8 - $39.51 $430,707 - $552,507	13,984 New	13,984 $474,000
Q4 2020 Feb 10, 2021	SELL	$23.34 - $32.22 $376,520 - $519,773	-16,132 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$17.61 - $31.86 $990,051 - $1.79 Million	-56,221 Reduced 77.7%	16,132 $414,000
Q2 2020 Aug 13, 2020	BUY	$14.35 - $26.64 $1.04 Million - $1.93 Million	72,353 New	72,353 $1.86 Million
Q4 2019 Feb 10, 2020	SELL	$7.26 - $38.49 $386,551 - $2.05 Million	-53,244 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$7.47 - $14.03 $397,732 - $747,013	53,244 New	53,244 $398,000
Q1 2019 May 13, 2019	SELL	$10.9 - $14.09 $213,214 - $275,614	-19,561 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$10.36 - $20.96 $352,032 - $712,220	-33,980 Reduced 63.47%	19,561 $223,000
Q3 2018 Nov 08, 2018	SELL	$17.77 - $22.9 $269,126 - $346,820	-15,145 Reduced 22.05%	53,541 $1.16 Million
Q2 2018 Aug 14, 2018	SELL	$17.33 - $23.4 $103,893 - $140,283	-5,995 Reduced 8.03%	68,686 $1.21 Million
Q1 2018 May 11, 2018	BUY	$15.16 - $25.49 $250,124 - $420,559	16,499 Added 28.36%	74,681 $1.57 Million
Q4 2017 Feb 09, 2018	BUY	$14.27 - $16.79 $286,769 - $337,411	20,096 Added 52.76%	58,182 $842,000
Q3 2017 Nov 15, 2017	BUY	$10.77 - $22.1 $261,883 - $537,383	24,316 Added 176.59%	38,086 $601,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,770	13,770 $171,000

Others Institutions Holding ITCI

# of Institutions

381

Shares Held

84M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Intra Cellular Therapies, Inc. Transaction History